课题基金 / 基金详情

NeTS-NR ROSS.Net: A Platform for Integrated Large-Scale Network Design of Experiments and Simulation

NeTS-NR ROSS.Net: A Platform for Integrated Large-Scale Network Design of Experiments and Simulation
NeTS-NR ROSS.Net:实验与仿真集成的大规模网络设计平台
批准号:
0435259
负责人:
Christopher Carothers
金额:
$0.0万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-01-01 至 2010-12-31

项目摘要

项目成果

Christopher Carothers的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
National Science FoundationNETS - Research in Network Technologies and Systems CISE/CNSABSTRACTProposal Number: 0435259Principal Investigator: Kalyanaraman, ShivkumarInstitution: Rensselaer Polytechnic InstituteProposal Title: NeTS-NR ROSS.Net: A Platform for Integrated Large-Scale Net-work Design of Experiments and SimulationPerformance analysis tools to aid design, analysis, understanding and operation of networking protocols on large-scale and in heterogeneous deployment con-texts are urgently needed in networking research. Though there are popular tools for small-scale analysis and emerging test-bed facilities, large-scale analy-sis requires tools such as scalable simulators, experiment design and empirical modeling engines (a.k.a "meta-simulation" tools). The overall goal of this project is to provide tools that significantly improve the way networking community de-signs, tunes, and studies network protocols, especially for target deployment in large-scale, heterogeneous and time-varying conditions. In particular, the pro-ject develops an experimentation platform, called "ROSS.Net", with meta-simulation and simulation capabilities. In order to rapidly interpret system be-havior, ROSS.Net employs large-scale experiment design tools that allow model-ing and optimization of protocol response, i.e. a response surface in a large-dimensional parameter space. The goal is to generate a unified search, optimi-zation and sparse empirical modeling framework with demonstrated ability to pose meaningful large-scale design questions and provide "good" models rapidly for on-line operation. For a researcher to selectively compose a set of experi-ments resulting in accurate answers to the questions posed by the model de-signer; ROSS.Net uses reversible computation techniques to enable memory-efficient optimistic parallel simulation and model construction. The work has immediate impact in applications broadly in the area of computer systems where large-scale design is crucial (e.g. operating systems, distributed systems). Particularly, features like fast-approximation and sparse modeling have poten-tial impact in areas far from computer networking such as include industrial quality control, agriculture, and bioinformatics.Dr. Admela JukanProgram Director, CISE/CNSAug 5, 2004.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MRI: Acquisition of a Next Generation, Data-Centric Supercomputer
  • 批准号:
    1828083
  • 项目类别:
    Standard Grant
  • 资助金额:
    $99.9万
  • 财政年份:
    2018
  • 负责人:
    Christopher Carothers
  • 依托单位:
III: Medium: Mining petabytes of data using cloud computing and a massively parallel cyberinstrument
  • 批准号:
    1302231
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $100.0万
  • 财政年份:
    2013
  • 负责人:
    Christopher Carothers
  • 依托单位:
MRI: Acquisition of a Balanced Environment for Simulation
  • 批准号:
    1126125
  • 项目类别:
    Standard Grant
  • 资助金额:
    $265.76万
  • 财政年份:
    2011
  • 负责人:
    Christopher Carothers
  • 依托单位:
CAREER: Scalable, High Performance Network Simulations Using Reverse Computation
  • 批准号:
    0133488
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $0.0万
  • 财政年份:
    2002
  • 负责人:
    Christopher Carothers
  • 依托单位:
国内基金
海外基金
ELOVL6通过NR2F1棕榈酰化驱动去势抵抗性前列腺癌交叉耐药的机制研究
  • 批准号:
    JCZRLH202600929
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
NR4A3在先天性纯红细胞再生障碍性贫血中的作用和机制研究
  • 批准号:
    JCZRLH202600268
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
大肠上皮生物钟核心基因NR1D1下调引起的染色质结构变化在IBS致病机制中的作用
  • 批准号:
    JCZRLH202600845
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
成纤维细胞中NR2F1-AS1协同KRAS通过PI3K/AKT/mTOR途径促进胰腺导管腺癌发展